Setting-up an in vitro model of rat blood-brain barrier (BBB): A focus on BBB impermeability and receptor-mediated transport

Journal of Visualized Experiments

Volumn , Issue 88, 2014, Pages

  Molino, Yves ^a   Jabès, Françoise ^a   Lacassagne, Emmanuelle ^b   Gaudin, Nicolas ^b   Khrestchatisky, Michel ^b  

^a VECT HORUS SAS ^*  (France)

^b Mediterranée University   (France)

Author keywords

Issue 88; LDLR; Low density lipoprotein (LDL); Medicine; Mouse; P glycoprotein (P gp); Rat brain endothelial cells (RBEC); Receptor mediated transport (RMT); Spinal cord; TfR; Tight junction (TJ); Transendothelial electrical resistance (TEER); Transferrin

Indexed keywords

CARBOCYANINE; CYANINE DYE 3; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 123;

ACTIVE TRANSPORT; ANIMAL; ANIMAL MODEL; ASTROCYTE; BIOSYNTHESIS; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CHEMISTRY; COCULTURE; CULTURE TECHNIQUE; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; MALE; METABOLISM; PROCEDURES; RAT; REPRODUCIBILITY; WISTAR RAT;

ANIMALS; ASTROCYTES; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; CARBOCYANINES; CELL CULTURE TECHNIQUES; CELL MEMBRANE PERMEABILITY; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; MALE; MODELS, ANIMAL; P-GLYCOPROTEIN; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; RHODAMINE 123;

EID: 84921949599     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51278     Document Type: Article

References (92)

1. Rubin, L.L., Staddon, J.M. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 22, 11-28 (1999).
2. Abbott, N.J. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25, 5-23 (2005).
3. Cecchelli, R., et al. Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov. 6 (8), 650-61 (2007).
4. Pekny, M., Stanness, K.A., Eliasson, C., Betsholtz, C., Janigro, D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia. 22 (4), 390-400 (1998).
5. Girouard, H., Iadecola, C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 100 (1), 328-35 (2006).
6. Dehouck, M.P., Méresse, S., Delorme, P., Fruchart, J.C., Cecchelli, R. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem. 54 (5), 1798-801 (1990).
7. Culot, M., et al. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol In Vitro. 22 (3), 799-811 (2008).
8. Zhang, Y., et al. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab Dispos. 34 (11), 1935-43 (2006).
9. Patabendige, A., Skinner, R.A., Abbott, N.J. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res.1521, 1-15 (2012).
10. Abbott, N.J., Dolman, D.E., Drndarski, S., Fredriksson, S.M. An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. Methods Mol Biol. 814, 415-30 (2012).
11. Nakagawa, S., et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int. 54 (3-4), 253-63 (2009).
12. Wilhelm, I., Fazakas, C., Krizbai, I.A. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars). 71 (1), 113-28 (2011).
13. Coisne, C., et al. Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab Invest. 85 (6), 734-46 (2005).
14. Josserand, V., et al. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. J Pharmacol Exp Ther. 316 (1), 79-86 (2006).
15. Lacombe, O., et al. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery. Mol Pharm. 8 (3), 651-63 (2011).
16. Nakagawa, S., et al. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol. 27 (6), 687-94 (2007).
17. Lippmann, E.S., Weidenfeller, C., Svendsen, C.N., Shusta, E.V. Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons. J Neurochem. 119 (3), 507-20 (2011).
18. Xue, Q., et al. A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. Int J Biol Sci. 9 (2), 174-89 (2013).
19. Sohet, F., Daneman, R. Genetic mouse models to study blood-brain barrier development and function. Fluids Barriers CNS. 10 (1), 3 (2013).
20. Shayan, G., Choi, Y.S., Shusta, E.V., Shuler, M.L., Lee, K.H. Murine in vitro model of the blood-brain barrier for evaluating drug transport. Eur J Pharm Sci. 42 (1-2), 148-55 (2011).
21. Cecchelli, R., et al. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev. 36 (2-3), 165-178 (1999).
22. Deli, M.A., Abrahám, C.S., Kataoka, Y., Niwa, M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol.25 (1), 59-127 (2005).
23. Perrière, N., et al. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res. 1150, 1-1 (2007).
24. Pardridge, W.M., Buciak, J.L., Friden, P.M. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther. 259 (1), 66-70 (1991).
25. Delbart, C., Fruchart, J.C., Cecchelli, R. Low-density lipoprotein receptor on endothelium of brain capillaries. J Neurochem. 53 (2), 340-5 (1989).
26. Gosselet, F., Candela, P., Sevin, E., Berezowski, V., Cecchelli, R., Fenart, L. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res. 1249, 34-42 (2009).
27. Pardridge, W.M. Vector-mediated drug delivery to the brain. Adv Drug Deliv Rev. 36 (2-3), 299-321 (1999).
28. Pardridge W.M., Boado, R.J. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol. 503, 269-92 (2012).
29. Boado, R.J., Lu, J.Z., Hui, E.K., Sumbria, R.K., Pardridge, W.M. Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor. Biotechnol Bioeng. 110 (5), 1456-65 (2013).
30. Ito, S., Ohtsuki, S., Terasaki, T. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier. Neurosci Res. 56 (3), 246-252 (2006).
31. Demeule, M., et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther. 324 (3), 1064-72 (2008).
32. Yamada, K., et al. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. J Biol Chem. 283 (50), 34554-62 (2008).
33. Gabathuler, R. New protein vectors for physiological transfer of therapeutic agents to the central nervous system. Biol Aujourdhui. 206 (3), 191-203 (2012).
34. Malcor, J.D., et al. Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting. J Med Chem. 55 (5), 2227-41 (2012).
35. Wang, D., et al. Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier. Proc Natl Acad Sci U S A.110 (8), 2999-3004 (2013).
36. Spencer, B.J., Verma, I.M. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci U S A. 104 (18), 7594-9 (2007).
37. Kreuter, J., et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target. 10 (4), 317-25 (2002).
38. Stamatovic, S.M., Keep, R.F., Andjelkovic, A.V. Brain endothelial cell-cell junctions: how to 'open' the blood brain barrier. Curr Neuropharmacol. 6 (3), 179-92 (2008).
39. Petty, M.A., Lo, E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol. 68 (5), 311-23 (2002).
40. Stephan, D., et al. TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation. 10 (9) (2013).
41. Descamps, L., Cecchelli, R., Torpier, G. Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J Neuroimmunol. 74 (1-2), 173-84 (1997).
42. Miller, F., et al. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model. Eur J Neurosci. 22 (4), 835-44 (2005).
43. Fillebeen, C., Dehouck, B., Benaïssa, M., Dhennin-Duthille, I., Cecchelli, R., Pierce, A. Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier. J Neurochem. 73 (6), 2491-500 (1999).
44. Zhang, Y., Schuetz, J.D., Elmquist, W.F., Miller, D.W. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. JPharmacol Exp Ther. 311 (2), 449-55 (2004).
45. Kane, R.L., Martínez-López, I., DeJoseph, M.R., Viña, J.R., Hawkins, R.A. Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem. 274 (45), 31891-5 (1999).
46. Kannan, R., Mittur, A., Bao, Y., Tsuruo, T., Kaplowitz, N. GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter. J Neurochem. 73 (1), 390-9 (1999).
47. Abbott, N.J., Hughes, C.C., Revest, P.A., Greenwood J. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci. 103 (1), 23-37 (1992).
48. Perrière, N., et al. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J. Neurochem.93 (2), 279-89 (2005).
49. Tsou, R., Isik, F.F. Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem. 224 (1-2), 81-9 (2001).
50. Helms, H.C., Waagepetersen, H.S., Nielsen, C.U., Brodin, B. Paracellular tightness and claudin-5 expression is increased in the BCEC/astrocyte blood-brain barrier model by increasing media buffer capacity during growth. AAPS J. 12 (4), 759-70 (2010).
51. Rubin, L.L., Sanes, J.R. Neuronal and glial cell biology. Curr Opin Neurobiol. 6 (5), 573-5 (1996).
52. Abbott, N.J. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 7 (1), 41-53 (2006).
53. Deracinois, B., et al. Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: a differential gel electrophoresis study. Proteomics.13 (7), 1185-99 (2013).
54. Haseloff, R.F., Blasig, I.E., Bauer, H.C., & Bauer, H. In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol. 25 (1), 25-39 (2005).
55. Mi, H., Haeberle, H., & Barres, B.A. Induction of astrocyte differentiation by endothelial cells. J Neurosci. 21 (5), 1538-47 (2001).
56. Abbott, N.J. Astrocyte endothelial interactions and blood-brain barrier permeability. J. Anat. 200 (6), 629-638 (2002).
57. Calabria, A.R., Weidenfeller, C., Jones, A.R., de Vries, H.E., Shusta, E.V. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem. 97 (4), 922-33 (2006).
58. Förster, C., et al. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J. Physiol. 565 (Pt. 2), 475 (2005).
59. Förster, C., Waschke, J., Burek, M., Leers, J., Drenckhahn, D. Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J. Physiol. 573(Pt. 2), 413 (2006).
60. Ge, S., Pachter, J.S. Isolation and culture of microvascular endothelial cells from murine spinal cord. J Neuroimmunol. 177 (1-2), 209-14 (2006).
61. Berezowski, V., Landry, C., Dehouck, M.P., Cecchelli, R., Fenart, L. Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier. Brain Res. 1018 (1), 1-9 (2004).
62. Duan, S., Anderson, C.M., Stein, B.A., Swanson, R.A. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci.19 (23), 10193-200 (1999).
63. Gegelashvili, G., Dehnes, Y., Danbolt, N.C., Schousboe, A. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int. 37 (2-3), 163-70 (2000).
64. Candela, P., et al. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium. 15(5-6), 254-64 (2008).
65. Dehouck, B., Dehouck, M.P., Fruchart, J.C., Cecchelli, R. Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol. 126 (2), 465-73 (1994).
66. Dehouck, B., Fenart, L., Dehouck, M.P., Pierce, A., Torpier, G., Cecchelli, R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol. 138 (4), 877-89 (1997).
67. Mahad, D.J., Ransohoff, R.M. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol. 15 (1), 23-32 (2003).
68. Glabinski A.R., Ransohoff, R.M. Chemokines and chemokine receptors in CNS pathology. J Neurovirol. 5 (1), 3-12 (1999).
69. Stamatovic, S.M., et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab. 25 (5), 593-606 (2005).
70. Semple, B.D., Kossmann, T., Morganti-Kossmann, M.C. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab. 30 (3), 459-73 (2010).
71. Veszelka, S., Nakagawa, S., Niwa, M., Deli, M.A. Patented in vitro blood-brain barrier models in CNS drug discovery. Recent Pat CNS Drug Discov. 6 (2), 107-118 (2011).
72. Patabendige, A. The value of in vitro models of the blood-brain barrier and their uses. Altern Lab Anim. 40 (6), 335-8 (2012).
73. Ogunshola, O.O. In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr Pharm Des. 17 (26), 2755-61 (2011).
74. Vandenhaute, E., et al. Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. Curr Neurovasc Res. 8 (4), 258-69 (2011).
75. Shawahna, R., Decleves, X., Scherrmann, J.M. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes. Curr Drug Metab. 14 (1), 120-36 (2013).
76. Vernon, H., Clark, K., Bressler, J.P. In vitro models to study the blood brain barrier. Methods Mol Biol. 758, 153-68 (2011).
77. Calabria, A.R., Shusta, E.V. A genomic comparison of in vivo and in vitro brain microvascular endothelial cells. J Cereb Blood Flow Metab. 28 (1), 135-48 (2008).
78. Uchida, Y., Ohtsuki, S., Kamiie, J., Terasaki, T. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice. J Pharmacol Exp Ther. 339 (2), 579-88 (2011).
79. Cucullo, L., Aumayr, B., Rapp, E., Janigro, D. Drug delivery and in vitro models of the blood-brain barrier. Curr Opin Drug Discov Devel. 8 (1), 89-99 (2005).
80. Naik, P., Cucullo, L. In vitro blood-brain barrier models: current and perspective technologies. J Pharm Sci. 101 (4), 1337-54 (2012).
81. Stanness, K.A., et al. A new model of the blood--brain barrier: co-culture of neuronal, endothelial and glial cells under dynamic conditions. Neuroreport. 10 (18), 3725-31 (1999).
82. Santaguida, S., et al. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study. Brain Res. 1109 (1), 1-13 (2006).
83. Cucullo, L., Marchi, N., Hossain, M., Janigro, D. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab. 31 (2), 767-77 (2011).
84. Cucullo, L., Hossain. M., Puvenna, V., Marchi, N., Janigro, D. The role of shear stress in Blood-Brain Barrier endothelial physiology. BMC Neurosci. 12 (40), (2011).
85. Cucullo, L., Hossain, M., Tierney, W., Janigro, D. A new dynamic in vitro modular capillaries-venules modular system: cerebrovascular physiology in a box. BMC Neurosci.14:18 (2013).
86. Qutub, A.A., Hunt, C.A. Glucose transport to the brain: a systems model. Brain Res Brain Res Rev. 49 (3), 595-617 (2005).
87. Neuhaus, W., et al. A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2. J Biotechnol. 125 (1), 127-41 (2006).
88. Roux, F., Couraud, P.O. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol. 25 (1), 41-58 (2005).
89. Weksler, B.B., et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (13), 1872-4 (2005).
90. Omidi, Y., et al. Evaluation of the immortalised mouse brain capillary endothelial cell line, b. End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res. 990 (1-2), 95-112 (2003).
91. Weksler, B., Romero, I.A., Couraud, P.O. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS. 10 (1), 16 (2013).
92. Cucullo, L., et al. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab. 28 (2), 312-28 (2008).